Persistent URL of this record https://hdl.handle.net/1887/105179
In Collections
This item can be found in the following collections:
Plasma biomarker analysis in patients with HER2-negative locally recurrent or metastatic breast cancer (LR/MBC) treated with first-line bevacizumab (A) and paclitaxel (T) without or with capecitabine (X)
- All authors
- Lam, S.W.; Nota, N.M.; Groot, S.M. de; Jager, A.; Bos, M.M.; Linn, S.C.; Bosch, J. van den; Braun, H.J.; Velden, A.M.T. van der; M. los; Portielje, J.E.A.; Kroep, J.R.; Honkoop, A.H.; Smorenburg, C.H.; Tanis, B.; Riel, J.M.G.H. van; Terwogt, J.M.M.; Boer, M.O. den; Douma, J.; Jeurissen, F.; Berends, J.; Tinteren, H. van; E. boven
- Date
- 2015-05-01
- Journal
- Cancer Research
- Volume
- 75
- Issue
- 9